Literature DB >> 25028705

Letter to the editor on 'Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small cell lung cancer'.

K Park1, J-M Sun2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25028705     DOI： 10.1093/annonc/mdu244

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  1 in total

1.  Progression-Free Survival and Time to Progression as Potential Surrogate Endpoints for Overall Survival in Chemoradiotherapy Trials in Limited-Stage Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Authors:  Yin Yang; Jianyang Wang; Wenqing Wang; Tao Zhang; Jingjing Zhao; Yu Wang; Yexiong Li; Luhua Wang; Nan Bi
Journal:  Front Oncol       Date:  2022-01-28       Impact factor: 5.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.